Stempeutics gets Japanese process patent for stem cell drug

Stempeutics Research has been granted a process patent from the Japan Patent Office for its novel stem-cell based drug Stempeucel. Stempeutics is part of the Manipal Education and Medical Group and entered into a strategic alliance with pharma major, Cipla …

[Read the full article here]

Comments are closed.